The standardized cannabinoid testing will allow labs to detect levels to a higher degree of precision (approximately 0.0001%). Labs will identify whether samples contain more than 0.0001% of controlled cannabinoids (equivalent to 1mg/kg).
The Association for the Cannabinoid Industry (The ACI) has today announced high-level discussions with the Laboratory of Government Chemists (LGC) that will focus on the development of a cannabinoid testing methodology.
UK trade group the Association for the Cannabinoid Industry says it has entered into discussions wit international life sciences testing company LGC in a move it says represents an ‘essential step towards standardisation for the CBD industry’.
The ACI announced today that, in partnership with the lab company Eurofins and the Laboratory of Government Chemists (LGC), a testing company and UK government advisor, it has set the first lab standards for detecting cannabinoids in CBD products sold in the UK.
The Association for the Cannabinoid Industry (ACI) today announced it is pressing ahead with trials on a new protocol in conjunction with UK Government chemists and testing firm Eurofins.
The announcememt comes after months of work by the Association for the Cannabinoid Industry, led by the head of its Regulatory and Compliance Unit Dr Parveen Bhatarah, to define protocols for the analytical testing of #cannabinoids.
The Association for the Cannabinoid industry aims to create a safe, legal and well regulated CBD market in the UK.
With time ticking down for CBD manufacturers to meet the UK’s deadline for having a validated EU novel food application in hand, two European hemp associations are pooling resources to meet the application’s requirements.
AS regulators on both sides of the Atlantic harry an untethered and ‘unsafe’ CBD industry, signs of a co-ordinated response are emerging.
With the deadline for novel food authorisation on the horizon for UK CBD companies, Shomi Malik, Development Director at The Association for the Cannabinoid Industry (ACI), outlines the steps that must be taken to ensure dossiers meet the required standards.
CBD is considered a novel food by European regulators. While many CBD products remain on the market, they have not been authorised by European authorities.
[Cannavist Magazine] Less than half of the CBD products on sale in the UK contain the amount advertised.
Professor Saoirse O’Sullivan, The Association for the Cannabinoid Industry Science Lead, said these UK findings are in line with similar studies conducted in other countries where CBD use has grown popular.
HBW Insight speaks to the founder of the UK’s Association for the Cannabinoid Industry, Steve Moore, about the organization’s new three-tier certification system for CBD products marketed in the country, designed to mirror the EU Novel Foods approval process as well as recent local regulatory changes.
[Food Navigator] Mile High submits CBD novelfoods dossier: ‘This paves the way for big companies operating in CBD’
Mile High Labs has submitted a European novel foods dossier for its CBD isolate.
Greg Foot talks to beauty columnist Sali Hughes and Saoirse O’Sullivan, an expert in cannabinoid research, to find out if these products really are The Best Thing Since Sliced Bread.
The Association for the Cannabinoid industry reveals details of a three-tiered certification scheme that looks to provide safety and quality assurances for cannabidiol (CBD) based products.
[Health Europa] The Association for the Cannabinoid Industry (The ACI) today outlined new plans for The ACI CBD Safety Certification programme.
The Association for the Cannabinoid Industry (ACI) Certification is a key part of The ACI’s vision for a sustainable future for the UK CBD sector and further emboldens The ACI’s mission to nurture an industry that puts public safety first.
The programme will be composed of three tiers, each representing the necessary steps to gaining full novel foods authorisation
After being presented with the summary the 2056 survey participants were asked how much they supported or opposed the FSA’s decision. 74% had a positive reaction (25% indicating ‘strongly support’, 39% indicating ‘tend to support’).
Asked how much they supported or opposed the guidance – following an FSA review on the evidence of CBD products – 74 per cent returned a positive response, while only 8 per cent chose to oppose.
[NutraIngredients] CBD sector warms to UK 2021 novel foods deadline; German Ministry says some extracts don’t need NF approval
ACI spokesperson Steve Moore told NutrIngredients each of its 30 members were engaged in dossier construction 0 with some aspects as toxicology data being compiled collectively
The poll also gave insight into CBD usage and awareness in the UK population, highlighting that 71% of respondents were aware of CBD, with 16% of them having already purchased a CBD product.
Fieldwork dates: 6th-9th March 2020Total sample size: 2065 adultsConducted by: YouGovOn Behalf of: The Association for the Cannabinoid Industry This survey data was collected and
The Association for the Cannabinoid Industry was launched at the end of October, providing a platform to aid the development of a legally compliant, socially responsible and innovative CBD industry.
Hayden Williamson from the Podcast CBD ReLeaf chats with The ACI Regulatory and Compliance Lead, Dr Parveen Bhatarah, The ACI Development Director, Shomi Malik, and Global Regulatory
The ACI’s Development and Quality Lead, Marc Burbidge, discusses recent announcements by the FSA, regarding CBD, in this wide ranging chat with Alexis Conran on
British food regulators have given the CBD industry a little over a year to apply for safety evaluations in order to remain on shelves, a landmark advancement as many nations have yet to decide whether cannabidiol can be sold in food.
The Food Standards Agency (FSA) today set a deadline of March 2021 for CBD manufacturers to prove their products are safe for human consumption, in a move that is expected to kill off a huge chunk of the industry because of the cost of conducting the necessary tests.
Oils, snacks and drinks containing the cannabis extract cannabidiol (CBD) will be “taken off the shelves” next year if they do not gain regulatory approval.
The Food Standards Agency (FSA) has asked CBD businesses to get their products registered by 31 March 2021 or risk being pulled. After the deadline, only products which have submitted a valid novel food authorisation application will be allowed to remain on the market.
At its current rate of growth, the CBD industry is predicted to be worth almost £1 billion per annum by 2025, eclipsing sales of vitamin D and vitamin C. Advocates suggest CBD has a host of health benefits, from easing anxiety and acne to soothing chronic pain.
It comes after the European Food Safety Authority last year classified all extracts of hemp and derived products containing cannabinoids, including CBD, as novel foods – meaning they require pre-market authorisation.
The Association for the Cannabinoid Industry (ACI) has announced its partnership with The Grocer as a diamond sponsor for the publication’s first ever CBD Global Summit.
The Association for the Cannabinoid Industry (ACI) says it has initiated the first steps towards processing applications from its raw-product manufacturing members for ‘novel foods’ authorisation.
Recent research commissioned by the Centre for Medicinal Cannabis has revealed that the UK CBD market is worth £300 million Cannabidiol, known more commonly as
The Centre for Medicinal Cannabis (CMC) has launched a trade association and introduced a quality charter for CBD manufacturers.
Last week saw the launch of a ground-breaking new industry body to foster a legally compliant, socially responsible and innovative cannabinoid industry.
[Pharmacy Businss] New trade body for cannabinoid industry promises compliance and social responsibility
Following a six-month consultation with key stakeholders, a trade association for the cannabinoid industry was launched last week.
Today marks the launch of the new regulatory body for CBD products in the UK. The new CBD regulation body, the Association for the Cannabinoid Industry (ACI),
[Hemp Industry Daily] Amid EU limits on CBD foods, UK industry group launches new effort to stay on store shelves
A new industry group launching in the United Kingdom on Friday aims to get a reprieve from European rules enforcement by working with food regulators when selling CBD products, a departure from hemp producers who are seeking to undo the rules.
Following an extensive six-month consultation with key stakeholders since the release of a landmark report ‘CBD in the UK‘, the new trade association, ACI, aimed at leading CBD industry regulation, is being launched at a ground-breaking CBD Summit on Friday, 8 November.
Following an extensive 6-month consultation with key stakeholders since the release of a landmark report “CBD in the UK”, a new trade association is being launched today (Friday 8th November) at a ground-breaking CBD Summit.